【摘要】 本文旨在阐述KRAS G12C突变型晚期非小细胞肺癌的治疗进展，重点探讨国内外抑制剂治疗及研究现状，介绍了靶向药物在临床治疗中单用和联用的研究成果，分析其在临床应用中的优势和面临挑战，并对未来可能出现的新的治疗手段进行展望。更多还原

【Abstract】 This article elucidates therapeutic approaches for KRAS G12C-mutant advanced non-small cell lung cancer, with focus on global advancements in inhibitor research. It also summarizes clinical evidence on the efficacy of targeted agents in monotherapy and combination therapies, analyzes their clinical advantages and challenges, and explores future directions for novel treatment modalities.更多还原